Include All CSL Sites

Locations - Our combined footprint

The combination of bioCSL with the influenza vaccine division of Novartis has created the second largest flu company in the world: Seqirus.

With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.